Secondary antioxidant enzymes (glutathione reductase, glucose-6-phosphate dehydrogenase, glutathione-s-transferase, and ubiquinone) detoxify ROS and supply the NADPH and glutathione for primary antioxidant enzymes for proper functioning
No prior authorization, no step therapy, and no formulary restrictions apply to PlexusDx compounds
Most users report mild, transient cardiovascular effects during initial use, with some experiencing temporary warmth or flushing from vasodilation
Methods This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to identify and evaluate in vitro studies investigating the effects of glucagon-like peptide-1 receptor agonists and their analogues on human mesenchymal stem cell functions, including proliferation, differentiation, signaling, apoptosis, and tissue-specific applications